The effect of parenteral selenium on outcomes of mechanically ventilated patients following sepsis: a prospective randomized clinical trial

Annals of Intensive Care

Volumn 5, Issue 1, 2015, Pages

  Chelkeba, Legese ^a,b,c   Ahmadi, Arezoo ^b   Abdollahi, Mohammad ^a   Najafi, Atabak ^b   Ghadimi, Mohammad Hosein ^a   Mosaed, Reza ^a   Mojtahedzadeh, Mojtaba ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c JIMMA UNIVERSITY   (Ethiopia)

Author keywords

Selenium; Septic shock; Severe sepsis; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; GLUTATHIONE PEROXIDASE; HYPERTENSIVE FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; SODIUM SELENITE; STEROID;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MECHANICAL VENTILATOR; MIDDLE AGED; PERITONITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPTIC SHOCK; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; VERY ELDERLY; YOUNG ADULT;

EID: 84943195677     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/s13613-015-0071-y     Document Type: Article

References (54)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10.
2. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med. 2003;168(2):165–72.
3. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–54.
4. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA. 1997;278(3):234–40.
5. Tanriover M, Guven G, Sen D, Unal S, Uzun O. Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country. Epidemiol Infect. 2006;134(02):315–22.
6. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181(1):176–80.
7. Cavaillon J-M. Pathophysiological role of pro- and anti-inflammatory cytokines in sepsis. Sepsis. 1998;2(2):127–40.
8. Kurt ANC, Aygun AD, Godekmerdan A, Kurt A, Dogan Y, Yilmaz E. Serum IL-1β, IL-6, IL-8, and TNF-α; Levels in early diagnosis and management of neonatal sepsis. Mediators of inflammation. 2007. http://www.ncbi.nlm.nih.gov/pubmed/18274637. Accessed July 15 2015.
9. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K-I, Nakamua M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine. 2005;29(4):169–75.
10. Manzanares WBA, Torre MH, Galusso F, Facchin G, Hardy G. High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Med. 2011;37(7):1120–7.
11. Grossman RF, Fein A. Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia: executive summary. Chest J. 2000;117(4_suppl_2):177S–81S.
12. Chastre J, Fagon J-Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867–903.
13. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33(10):2184–93.
14. Amin A. Clinical and economic consequences of ventilator-associated pneumonia. Clin Infect Dis. 2009;49(1):36–43.
15. Bouadma L, Sonneville R, Garrouste-Orgeas M, Darmon M, Souweine B, Voiriot G, et al. Ventilator-associated events: prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit Care Med. 2015;43(9):1798–806.
16. Driscoll DM, Copeland PR. Mechanism and regulation of selenoprotein synthesis. Annu Rev Nutr. 2003;23(1):17–40.
17. de Vega JMA, Díaz J, Serrano E, Carbonell LF. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med. 2002;30(8):1782–6.
18. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med. 2003;31(4):1048–52.
19. Vunta H, Belda BJ, Arner RJ, Channa Reddy C, Vanden Heuvel JP, Sandee pPrabhu K. Selenium attenuates pro-inflammatory gene expression in macrophages. Mol Nut Food Res. 2008;52(11):1316–23.
20. Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, Thompson JT, et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Δ12, 14-prostaglandin J2 in macrophages. J Biol Chem. 2007;282(25):17964–73.
21. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med. 1998;26(9):1536–44.
22. Valenta J, Brodska H, Drabek T, Hendl J, Kazda A. High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med. 2011;37(5):808–15.
23. Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2011;342:1542. http://www.bmj.com/content/342/bmj.d1542. Accessed July 14, 2015.
24. Kong Z, Wang F, Ji S, Deng X, Xia Z. Selenium supplementation for sepsis: a meta-analysis of randomized controlled trials. Am J Emerg Med. 2013;31(8):1170–5.
25. Miller N, Miller M, Hill LT. The impact of antioxidant supplementation on clinical outcomes in the critically ill: a meta-analysis. South Afr J Crit Care. 2013;29(1):18–26.
26. Visser J, Labadarios D, Blaauw R. Micronutrient supplementation for critically ill adults: a systematic review and meta-analysis. Nutrition. 2011;27(7):745–58.
27. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228.
28. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest J. 1992;101(6):1644–55.
29. Rello J, Lode H, Cornaglia G, Masterton R. A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med. 2010;36(5):773–80.
30. Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock*. Crit Care Med. 2007;35(1):118–26.
31. Mishra V, Baines M, Elizabeth Perry S, Jeremy McLaughlin P, Carson J, Wenstone R, et al. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clinical Nutrition. 2007;26(1):41–50.
32. Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach J-M, et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care. 2007;11(4):73.
33. Manzanares W, Biestro A, Torre MH, Galusso F, Facchin G, Hardy G. High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Med. 2011;37(7):1120–7.
34. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–11.
35. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496.
36. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–93.
37. Manzanares W, Dhaliwal R, Jiang X, Murch L, Heyland DK. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care. 2012;16(2):R66.
38. Landucci F, Mancinelli P, De Gaudio AR, Virgili G. Selenium supplementation in critically ill patients: a systematic review and meta-analysis. J Crit Care. 2014;29(1):150–6.
39. Alhazzani W, Jacobi J, Sindi A, Hartog C, Reinhart K, Kokkoris S, et al. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2013;41(6):1555–64.
40. Huang T-S, Shyu Y-C, Chen H-Y, Lin L-M, Lo C-Y, Yuan S-S, et al. Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis. PLoS One. 2013;8(1):e54431.
41. Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005;31(3):327–37.
42. Huang Z, Rose AH, Hoffmann PR. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2012;16(7):705–43.
43. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest J. 1997;112(6):321–9.
44. Ulloa L, Tracey KJ. The ‘cytokine profile’: a code for sepsis. Trends Mol Med. 2005;11(2):56–63.
45. Pontes-Arruda A, Aragão AMA, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006;34(9):2325–33.
46. Landesberg G, Levin PD, Gilon D, Goodman S, Georgieva M, Weissman C, et al. Myocardial dysfunction in severe sepsis and septic shock—no correlation with inflammatory cytokines in real-life clinical setting. Chest. 2015;148(1):93–102.
47. Berger MM, Baines M, Raffoul W, Benathan M, Chiolero RL, Reeves C, et al. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr. 2007;85(5):1293–300.
48. Berger MM, Eggimann P, Heyland DK, Chioléro RL, Revelly J-P, Day A, et al. Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials. Crit Care. 2006;10(6):153.
49. Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset: ventilator-associated pneumonia in determining patient mortality. Chest J. 1995;108(6):1655–62.
50. Valles J, Pobo A, Garcia-Esquirol O, Mariscal D, Real J, Fernandez R. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early versus late onset. Intensive Care Med. 2007;33(8):1363–8.
51. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med. 2001;29(12):2303–9.
52. Moine P, Timsit J-F, De Lassence A, Troché G, Fosse J-P, Alberti C, et al. Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study. Intensive Care Med. 2002;28(2):154–63.
53. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.
54. Chelkeba L, Ahmadi A, Abdollahi M, Najafi A, Mojtahedzadeh M. Early goal-directed therapy reduces mortality in adult patients with severe sepsis and septic shock: systematic review and meta-analysis. Indian J Crit Care Med. 2015;19(7):401–11.